These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

158 related articles for article (PubMed ID: 3932688)

  • 1. Chemotherapy for bladder cancer.
    Whitmore WF
    J Urol; 1985 Dec; 134(6):1181-2. PubMed ID: 3932688
    [No Abstract]   [Full Text] [Related]  

  • 2. In vitro study of the interaction of doxorubicin, thiotepa, and mitomycin-C, agents used for intravesical chemotherapy of superficial bladder cancer.
    Seraphim LA; Perrapato SD; Slocum HK; Rustum YM; Huben RP
    J Urol; 1991 Mar; 145(3):613-7. PubMed ID: 1900087
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Intravesical thiotepa and mitomycin C treatment immediately after transurethral resection and later for superficial (stages Ta and Tis) bladder cancer: a prospective, randomized, stratified study with crossover design.
    Zincke H; Benson RC; Hilton JF; Taylor WF
    J Urol; 1985 Dec; 134(6):1110-4. PubMed ID: 3932685
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Intravesical chemotherapy: how effective is it?
    Heney NM
    Urology; 1988 Mar; 31(3 Suppl):17-9. PubMed ID: 3126591
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Intensive intravesical chemotherapy in the treatment of flat carcinoma in situ: is it safe?
    Droller MJ; Walsh PC
    J Urol; 1985 Dec; 134(6):1115-7. PubMed ID: 3932686
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Intravesical chemotherapy.
    Prout GR
    Prog Clin Biol Res; 1984; 162B():125-50. PubMed ID: 6438639
    [No Abstract]   [Full Text] [Related]  

  • 7. First-line chemotherapy of superficial bladder cancer: mitomycin vs thiotepa.
    Heney NM
    Urology; 1985 Oct; 26(4 Suppl):27-9. PubMed ID: 3931325
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A trial of prophylactic thiotepa or mitomycin C intravesical therapy in patients with recurrent or multiple superficial bladder cancers.
    Flanigan RC; Ellison MF; Butler KM; Gomella LG; McRoberts JW
    J Urol; 1986 Jul; 136(1):35-7. PubMed ID: 3086575
    [TBL] [Abstract][Full Text] [Related]  

  • 9. In vitro chemosensitivity of human bladder cancer.
    Weisenthal LM; Lalude AO; Miller JB
    Cancer; 1983 Apr; 51(8):1490-6. PubMed ID: 6186358
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Choosing the right intravesical chemotherapeutic agent. Results of an in vitro monolayer cell culture assay.
    Whelan P; Flynn C; Ramsden C
    Br J Urol; 1984 Dec; 56(6):655-7. PubMed ID: 6442872
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Treatment of superficial carcinoma of the bladder.
    Paulson DF
    Prog Clin Biol Res; 1984; 162B():193-209. PubMed ID: 6209720
    [No Abstract]   [Full Text] [Related]  

  • 12. Systemic therapy of bladder cancer.
    Salem PA
    Prog Clin Biol Res; 1984; 162B():95-105. PubMed ID: 6209726
    [No Abstract]   [Full Text] [Related]  

  • 13. Combined thiotepa and mitomycin C instillation therapy for low-grade superficial bladder tumor.
    Hu KN; Kim A; Khan AS; Soroff H; Gonder M
    Cancer; 1985 Apr; 55(8):1654-8. PubMed ID: 3156664
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Chemotherapy of bladder neoplasms--studies of preventive measures against recurrence of superficial bladder neoplasms].
    Okajima E; Motomiya Y; Ishuin M; Ikuma S; Ohara S
    Nihon Rinsho; 1977 May; 35(5):1987-91. PubMed ID: 407385
    [No Abstract]   [Full Text] [Related]  

  • 15. Microcapsule chemoembolization therapy: a new approach to bladder cancer.
    Kato T
    Prog Clin Biol Res; 1984; 162B():359-63. PubMed ID: 6209723
    [No Abstract]   [Full Text] [Related]  

  • 16. Clinical trials in superficial and invasive bladder cancer.
    Smith PH
    Turk J Pediatr; 1984; 26(1-4):251-63. PubMed ID: 6443168
    [No Abstract]   [Full Text] [Related]  

  • 17. Treatment of superficial bladder cancer with intravesical mitomycin C: analysis of immediate and long-term response in 70 patients.
    Soloway MS
    J Urol; 1985 Dec; 134(6):1107-9. PubMed ID: 3932684
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Introduction and overview of intravesical therapy for superficial bladder cancer.
    Soloway MS
    Urology; 1988 Mar; 31(3 Suppl):5-16. PubMed ID: 3126593
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Long-term mitomycin C instillation after transurethral resection of superficial bladder carcinoma: influence on recurrence, progression and survival.
    Huland H; Otto U; Droese M; Klöppel G
    J Urol; 1984 Jul; 132(1):27-9. PubMed ID: 6427483
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Studies of mitomycin C absorption after intravesical treatment of superficial bladder tumors.
    Wajsman Z; Dhafir RA; Pfeffer M; MacDonald S; Block A; Dragone N; Pontes JE
    J Urol; 1984 Jul; 132(1):30-3. PubMed ID: 6427484
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.